“…Fifteen genotypes are clearly linked to the development of adenocarcinoma and squamous cell carcinoma of the cervix and therefore rank as high-risk: HPV-16, -18, -31, -33, -35, -39, -45, -51, -52, -56, -58, -59, -68, -73, and -82. Twelve genotypes are either not potentially oncogenic, or not involved in the development of cervical cancer, and are considered low-risk: HPV-6, -11, -40, -42, -43, -44, -54, -61, -70, -72, -81, and CP6108 (1,2) Increasing evidence suggests that multiple factors contribute to the development of cervical cancer, including genetic susceptibility or host genome, HPV variants, coinfection of HPV and other agents, and life-style factors (3). Although all genotypes of HPV correlate with cervical cancers, HPV-16 and HPV-18 infection accounts for about 70% of all cases.…”